| Budget impact of metformin 1g immediate release tablet prescribing |
Prescribing bulletin |
February 2023 |
| Formulary assessment – Glucagon (Ogluo) |
Formulary assessment tools |
October 2022 |
| Comparison of DPP-4 inhibitors (Gliptins) |
Prescriber Support Tools |
October 2022 |
| Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart |
Evaluation report |
March 2022 |
| Flash glucose monitoring prescribing update – Freestyle Libre |
Prescribing for Population Health |
October 2020 |
| Oral semaglutide for the treatment of type 2 diabetes mellitus |
New Drug Evaluations |
October 2020 |
| Comparison of GLP 1 Agonists (update November 2020) |
Prescriber Support Tools |
November 2020 |
| Comparison of SGLT2 inhibitors (update) |
Prescriber Support Tools |
February 2020 |
| Insulin glargine plus lixisenatide (Suliqua) for the treatment of T2DM |
New Drug Evaluations |
August 2019 |
| Ertugliflozin for type 2 diabetes |
New Drug Evaluations |
January 2019 |
